Who
Philippe Sauvage
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Nuvation Bio.
In numbers
- Trades disclosed
- 20
- Buys
- 2
- Sells
- 1
- Bought
- $13K
- Sold
- $573K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Oct 2024
- Last trade
- 15 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jul 2026filed 17 Jul 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $87K39,999 at $2.17 | filing |
| 15 Jul 2026filed 17 Jul 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $21 at $1.97 | filing |
| 15 Jul 2026filed 17 Jul 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —39,999 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —39,999 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —1 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —1 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $87K39,999 at $2.17 | filing |
| 15 Jul 2026filed 17 Jul 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $21 at $1.97 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $103K47,668 at $2.17 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $286K47,668 at $6.01 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —47,668 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —47,668 at $0.00 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $103K47,668 at $2.17 | filing |
| 23 Jun 2026filed 24 Jun 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $286K47,668 at $6.01 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —748,130 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —748,130 at $0.00 | filing |
| 17 Jun 2025filed 18 Jun 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Bought | $7,1604,000 at $1.79 | filing |
| 16 Jun 2025filed 18 Jun 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Bought | $6,0723,300 at $1.84 | filing |
| 28 Feb 2025filed 4 Mar 2025 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 7 Oct 2024filed 9 Oct 2024 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
News
Critical Review: Nuvation Bio (NYSE:NUVB) vs. OSR (NASDAQ:OSRH)NUVB · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Philippe Sauvage; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.